The first participant has been dosed in a large clinical trial testing the experimental oral therapy votoplam (formerly PTC518) in adults with early-stage Huntington’s disease. That’s according to a press release from PTC Therapeutics, the therapy’s original developer, announcing its latest financial results and business updates.
Discussion
My wife, Jill, who is gene-positive with Huntington’s disease (HD), shared a serious issue she’s been struggling with lately: “I hate showers, and if I hate them now, how will I push through the uncomfortableness when several HD symptoms make it too difficult?” she said. This was not the…
Discussion
Editor’s note: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. There is also an online chat at 988lifeline.org. Internationally, find a suicide prevention helpline at findahelpline.com. While Huntington’s…
May marks Huntington’s Disease Awareness Month, and organizations worldwide are promoting greater awareness and understanding of the condition, as well as support for patients, families, and caregivers affected by it. Huntington’s disease (HD) is a genetic disorder that causes progressive damage and death to nerve cells in the brain.
Becoming educated and informed about Huntington’s disease is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Huntington’s disease journey.
There is no cure for Huntington’s disease yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
